 Home > Active Ingredient News > Antitumor Therapy > Chia Tai Tianqing approved the third high-end generic drug this year, pointing to Merck's heavy variety

Chia Tai Tianqing approved the third high-end generic drug this year, pointing to Merck's heavy variety

 Last Update: 2021-05-23
 Source: Internet
 Author: User

Tags

what high sugar level

1 4 inch

Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

Recently, Chia Tai Tianqing Pharmaceutical Group's application for the imitation of aprepitant capsules in category 4 was approved, making it the second domestic pharmaceutical company to be approved for the product and deemed to have been reviewed.

Figure 1: Details of approved products

Source: NMPA official website

Aprepitant is mainly used to prevent acute and delayed nausea and vomiting during the initial and repeated treatment of highly emetic anti-tumor chemotherapy.

Figure 2: Sales of Aprepitant Capsules

Source: Mi Nei.

According to data from Minai.

Table 1: High-end generic drugs approved by Chia Tai Tianqing Pharmaceutical Group since 2021

Source: Meinenet MED2.

Since 2021, CP Tianqing Pharmaceutical Group has approved 3 high-end generic drugs (Category 3, Category 4) for listing.

Table 2: Chia Tai Tianqing Pharmaceutical Group's listing applications under review since 2018

Source: Meinenet MED2.

Chia Tai Tianqing Pharmaceutical Group’s applications for the listing of generic drugs under review from 2018 to the present are all declared according to the new classification.

This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.